| Financial Year |
March 31 2023 |
| Monetary Funds |
192,880,851.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
334,924.17 |
| Accounts Receivable |
93,548,137.51 |
| Advances to Suppliers |
31,445,798.50 |
| Other Receivables |
87,193,595.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
74,661,188.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,185,363.29 |
| Total Current Assets |
486,123,336.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
260,282,012.93 |
| Investment Properties |
237,890,919.07 |
| Fixed Assetes |
255,983,245.55 |
| Under-construction Projects |
17,996,568.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,334,386.72 |
| R&D expenses |
-- |
| Goodwill |
3,438,138.12 |
| Long-Term Deferred and Prepaid Expenses |
14,537,393.84 |
| Deferred Income Tax Assets |
24,775,590.53 |
| Other Non-Current Assets |
2,424,544.30 |
| Sub-Total of Non-Current Assets |
933,665,799.39 |
| Total Assets |
1,419,789,135.92 |
| Short-Term Loans |
147,400,958.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,260,000.00 |
| Accounts Payable |
78,679,578.93 |
| Accounts Received In Advance |
6,555,294.35 |
| Employee Compensation Payable |
-- |
| Taxes Payable |
7,468,081.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,987,882.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,686,843.44 |
| Other Current Liabilities |
509,589,270.91 |
| Sub-Total of Current Liabilities |
849,788,572.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
144,195,070.83 |
| Deferred Income Tax Liabilities |
3,118,566.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
147,313,637.20 |
| Total Liabilities |
997,102,210.01 |
| Paid-In Capital(Or Share Stock) |
407,904,620.00 |
| Capital Surplus |
717,875,736.74 |
| Surplus Reserve |
21,281,039.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-722,933,321.89 |
| Minority Stockholder's Interest |
-1,441,148.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
424,128,074.20 |
| Owner's Equity（Stockholder's Equity） |
422,686,925.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,419,789,135.92 |
